Copley Scientific, the world’s leading manufacturer and supplier of inhaler testing equipment has acquired Novi Systems, a company with market-leading expertise in the automation of inhaler testing, extending the Copley product range and securing a broader platform for the development of new inhaler testing solutions.
‘We’ve known and respected Novi for many years,’ said Mark Copley, CEO, Copley Scientific, ‘and the two companies are highly complementary with a strong set of shared values. Like Copley, Novi is a UK-based family business, with a ‘can do’ problem solving approach and a reputation for engineering excellence. I’m particularly looking forward to working with Adam Smith who will head up the Automation Division at Copley Scientific, as we continue to develop and evolve our range of advanced inhaler testing solutions. Our combined strengths will undoubtedly provide customers of both companies with new opportunities to streamline and enhance their inhaler testing capabilities.’
Founded in 1993, Novi designs and manufactures modular and integrated systems for the automation of inhaler testing, including the IctusTM automated Andersen Cascade Impactor, with an impressive 25-year heritage. The well-established Vertus® products are flexible, automated shake, fire and flow control systems for delivered dose uniformity and cascade impactor testing of metered-dose inhalers (MDIs), while the DecaVertus® sets the benchmark for automated fire to waste, handling up to ten conventional or breath-actuated MDIs at a time. Both systems enhance the integrity and reproducibility of MDI test data, at the same time reducing the manual labour associated with shaking and firing; the former having recently been enhanced to measure shot weight and for use with nasal sprays.
‘The Copley name is synonymous with inhaler testing and we are delighted to be joining such a strong company,’ said Malcolm Smith, Founder and Managing Director of Novi Systems. ‘Our businesses share a commitment to exemplary customer service and I’m particularly pleased that Novi customers will benefit from an extended knowledge base, as well as a broader global distribution and support network. Mark has a clear vision for Copley Scientific and we’re looking forward to being part of a very bright future.’
Copley supplies equipment for testing MDIs, dry powder inhalers, nebulisers and nasal sprays, including apparatus required by the international pharmacopoeias and regulatory bodies for aerodynamic particle size distribution and delivered dose uniformity measurements. Founded over 70 years ago the company has signalled significant expansion over the course of the last year with a series of senior level appointments and a doubling in size of the Nottingham headquarters. Novi will join and fully integrate with the current Copley team in this newly opened building later this year.
23rd April 2019: Nottingham, UK
Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing.
Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products – metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays – with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals.
Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products. www.copleyscientific.com
Since 1993 Novi Systems has been using its engineering expertise to create solutions for the automation of inhaler testing. Its aim is to continually strive to deliver innovative solutions in a highly regulated sector. Novi provides an end-to-end service from product design, procurement, construction, testing and after sales support. Its dedicated team of engineers are skilled in mechanical, software and systems disciplines. Novi are experts in automation. www.novi.co.uk
Press information/Company contact:
Rosanna Lowe, Technical Marketing Executive, Copley Scientific Limited
Colwick Quays Business Park, Private Road No. 2, Colwick, Nottingham, NG4 2JY, UK Tel: +44 (0)115 961 6229
Fax: +44 (0)115 961 7637